Endocarditis Flashcards
Risk Factors Predisposing for Infective Endocarditis
- Presence of a ___ valve (highest risk)
- Previous endocarditis (highest risk)
- Acquired valvular dysfunction
- Mitral valve prolapse with regurgitation
- IV drug use
- Congenital heart disease
- Cardiac implantable devices
- Surgically constructed systemic pulmonary shunts or conduits
- Hypertrophic cardiomyopathy
- prosthetic
Etiologic Microorganisms in Infective Endocarditis
___ (30-70% of cases)
- S. aureus – most common (also in IV drug use)
- Myocardial abscesses (with conduction disturbances), purulent pericarditis, and valve ring abscesses are more common
- Early PVE – S. aureus and coagulase-negative staphylococci
___ (10-28% of cases)
- More common in patients with underlying cardiac ___ (e.g., mitral valve prolapse, rheumatic heart disease)
- Staphylococci
- viridans Streptococci
- abnormalities
Etiologic Microorganisms in Infective Endocarditis
Enterococci (5-18% of cases)
- ___ , ___
- Affects older men after GU procedure and younger women after OB procedure
- Primarily infects ___ heart valves (capable of attacking normal heart valves, causing destruction)
Fastidious gram-negative coccobacilli (5-10% of cases)
- Part of upper respiratory tract and oropharyngeal flora
- ___ group
Fungi
- Mostly seen in those who abuse narcotics, patients after reconstructive cardiovascular surgery, patients after prolonged IV and/or antibiotic therapy
- Poor prognosis (large ___ )
- E. faecalis, E. faecium
- abnormal
- HACEK
- vegetation
Pathophysiology
- Bacterial growth in vegetation is unimpeded due to lack of host defenses.
- Inoculum may reach 10^9 to 10^10 CFU/gram of tissue
- Valvular tissue may be destroyed with ___ formation
- vegetation
Clinical Presentation
Highly variable and non specific – depends on chronicity of infection
- Fever (95%)
- Malaise
- Fatigue
- Chills
- Heart murmur
- Embolic phenomena
- Skin manifestations
- Weakness
- Dyspnea
- Night sweats
- Weight loss
Laboratory Findings
Hematologic
- Normochromic, normocytic anemia (70-90%)
- Leukocytosis (5-15%) – may be normal to slightly elevated
Increased ESR and CRP
Urinalysis
- Proteinuria
- Microscopic hematuria
Blood cultures – single most important laboratory test
- Bacteremia is ___ and low grade (< 100 CFU/ml blood)
- Draw at least ___ sets from different sites initially, then 2 sets q __ - __ days
- Culture and susceptibility testing
- continuous
- 3
- 2-3
Clinical Stigmata of Endocarditis:
Peripheral Manifestations
- Osler’s nodes
- Janeway lesions
- Splinter hemorrhages
- Petechiae
- Roth spots
Diagnosis of Endocarditis: major criteria (3)
Diagnosis of Endocarditis: major criteria (3)
1) microbio
2) imaging
3) surgical
Diagnosis of Endocarditis: minor criteria - predisposition
- Previous history of IE
- Prosthetic valve
- Previous valve repair
- Congenital heart disease
- More than mild regurgitation or stenosis of any etiology
- Endovascular intracardiac implantable electronic device
- Hypertrophic obstructive cardiomyopathy
- Injection drug use
Diagnosis of Endocarditis: minor criteria - clinical symptoms
- fever
- Vascular phenomena
- Immunologic phenomena
Treatment – General Considerations
Complete eradication of organisms takes weeks to achieve
- Shortest duration is __ weeks, but __ - __ weeks (or longer) needed depending on organism, organism susceptibility, native valve vs. prosthetic valve
- vegetation; cells may exist in a state of reduced metabolic activity and cell division; potential for ___ subpopulations
Begin ___ dose, ___ antibiotics based on the most likely pathogen(s)
Bactericidal activity is required; synergistic combinations needed for some pathogens
- 2, 4-6
- resistant
- high, empiric
T or F: Begin counting days for treatment duration on first day of negative blood cultures
TRUE
Viridans Group Streptococci and S. gallolyticus - Native Valve
Highly Penicillin Susceptible
- ___ or ___ 4 weeks
- ___ + ___ 2 weeks
- ___ + ___ 2 weeks
- ___ 4 weeks
- PCN, Ceftriaxone
- PCN, gentamicin
- ceftriaxone, gentimicin
- vanc
Viridans Group Streptococci and S. gallolyticus - Native Valve
Penicillin “Relatively” Resistant
- ___ (4 weeks) + ___ (2 weeks)
- ___ (4 weeks) + ___ (2 weeks)
- ___ (4 weeks)
- PCN, gent
- cefriaxone, gent
- vanc
Ampicillin 2 g IV q4h is reasonable
Viridans Group Streptococci and S. gallolyticus - Prosthetic Valve
Penicillin Susceptible
- ___ (6 weeks) +/- gent (2 weeks)
- ___ (6 weeks) +/- gent
- ___ (6 weeks)
- PCN
- ceftriaxone
- vanco
if S, we dont really need gent
Viridans Group Streptococci and S. gallolyticus - Prosthetic Valve
Penicillin Relatively or Fully Resistant
- ___ (6 weeks) + ___ (6 weeks)
- ___ (6 weeks) + ___ (6 weeks)
- ___ (6 weeks)
- PCN, gent
- ceftriaxone, gent
- vanc
Staphylococci – Native Valve Endocarditis
MSSA
- ___ or ___ (6 weeks)
- allergic - non-anaphylactic: ___ (6 weeks)
MRSA
- ___ or ___ (6 weeks)
- nafcillin, oxacillin
- cefazolin
- vanc, dapto
Daptomycin and Staphylococcal Endocarditis
FDA-approved for ___ sided endocarditis
- Minimum of __ - __ days for uncomplicated infection; __ - __ days for complicated disease
Higher doses up to 10 mg/kg have demonstrated increased rate of
bacterial killing
- may reduce emergence of resistance
right
- 14-28
- 28-42
MRSA Alternatives in Endocarditis
___ - Reserved for salvage therapy
- Case reports suggest that ceftaroline plus daptomycin may be an option in reatment refractory ___ infections
Ceftaroline
S. aureus
MRSA Alternatives in Endocarditis
linezolid and tedizolid
both are kinda eh
- not great evidence
Staphylococci – Prosthetic Valve Endocarditis
oxacillin susceptible
___ or ___ (≥6 weeks) + ___(≥6 weeks) + ___ (2 weeks)
oxacillin resistant
___ (≥6 weeks) + ___ (≥ 6 weeks) + ___ (2 weeks)
- nafcillin, oxacillin, rifampin, gentamicin
- vanc, rifampin, gentamicin
Enterococci – Native or Prosthetic Valve
Penicillin- and Gentamicin-Susceptible
- ___ + ___ (4-6 weeks)
- ___ + ___ (4-6 weeks)
- ___ + ___ (6 weeks)
Prosthetic valve: __ weeks
- last regiment for pts with CrCl < 50
- ampicillin, gent
- PCN, gent
- ampicillin, ceftriaxone
- 6
Enterococci – Native or Prosthetic Valve
Penicillin-Susceptible & Aminoglycoside-Resistant
- ___ + ___ (6 weeks)
Penicillin-Susceptible, Streptomycin-Susceptible, Gentamicin-Resistant
- ___ + ___ (4-6 weeks)
- ___ + ___ (4-6 weeks)
- ampicillin, ceftriaxone
- ampicillin, streptomycin
- PCN, streptomycin
Enterococci – Native or Prosthetic Valve Endocarditis
Vancomycin Regimens in Patients Unable to Tolerate β-Lactam Therapy; Vancomycin and Aminoglycoside-Susceptible Strains
- ___ + ___ (6 weeks)
Intrinsic Resistance to Penicillin or β-Lactamase-Producer
- ___ + ___ (6 weeks)
- vanco, gent